Koers MediPal Holdings Corporation Other OTC
Aandelen
MAHLY
US58502T1079
Farmaceutische producten
Omzet 2024 * | 3.527 mld. 22,82 mld. 21,2 mld. | Omzet 2025 * | 3.561 mld. 23,05 mld. 21,41 mld. | Marktkapitalisatie | 519 mld. 3,36 mld. 3,12 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 35,7 mld. 231 mln. 215 mln. | Nettowinst (verlies) 2025 * | 35,68 mld. 231 mln. 214 mln. | EV/omzet 2024 * | 0,15 x |
Nettoliquiditeiten 2024 * | - 0 0 | Nettoliquiditeiten 2025 * | - 0 0 | EV/omzet 2025 * | 0,15 x |
K/w-verhouding 2024 * |
14,6
x | K/w-verhouding 2025 * |
14,8
x | Werknemers | - |
Dividendrendement 2024 * |
2,43% | Dividendrendement 2025 * |
2,54% | Vrij verhandelbaar | 84,27% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Shuichi Watanabe
PSD | President | 72 | 01-04-00 |
Midori Ito
CMP | Compliance Officer | - | - |
Takeshi Yanagida
CMP | Compliance Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Shuichi Watanabe
PSD | President | 72 | 01-04-00 |
Toshihide Yoda
BRD | Director/Board Member | 61 | 01-06-10 |
Director/Board Member | 69 | 01-04-77 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+16,66% | 70,09 mld. | |
-1,58% | 24,01 mld. | |
+8,01% | 8,32 mld. | |
-18,28% | 8,23 mld. | |
0,00% | 8,08 mld. | |
+4,40% | 4,68 mld. | |
+16,55% | 4,41 mld. | |
-0,70% | 4,12 mld. | |
-2,20% | 3,88 mld. |